这种HNRNPC/CELF2信号通路驱动了抗药性急性髓性白血病中的糖分重编程和线粒体功能障碍
Xiang Ma1, Haodong Li1, Ziqi Zhao2
1Laboratory of Biochemistry and Pharmacy, Taiyuan Institute of Technology, No. 31, Xinlan Road, Jiancaoping District, Taiyuan, 030008, Shanxi, People's Republic of China.
HNRNPC/CELF2通路驱动急性髓性白血病 (AML) 的代谢变化,有助于药物耐药性. 针对这一轴可能会改善AML治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 急性髓性白血病 (AML) 是一种具有攻击性的癌症,其特点是高耐治疗性和患者的不良结果.
- 代谢重编程对于AML的进展至关重要,影响药物耐药性和瘤存活率.
- 需要对HNRNPC/CELF2信号通路在AML细胞代谢和耐药性中的作用进行研究.
研究的目的:
- 为了研究HNRNPC/CELF2信号通路.
- 确定该途径对急性髓性白血病细胞代谢的影响.
- 为了阐明该途径在化疗耐药性中的作用.
主要方法:
- 通过m6 A修改研究了HNRNPC对CELF2表达的调节.
- 在耐药AML细胞中分析了代谢特征 (糖解,葡萄糖消耗,乳酸生产,线粒体功能).
- 利用基因淘汰和过度表达技术 (HNRNPC,CELF2) 来评估对细胞代谢和入侵/迁移的影响.
主要成果:
- 在HNRNPC中,通过m6A修饰来调节CELF2表达.
- 在耐药AML细胞中,增加的HNRNPC和降低的CELF2与上调的葡萄糖分解,增强的葡萄糖吸收,增加的乳酸盐和线粒体功能障碍相关.
- 降低HNRNPC降低了糖解和入侵;CELF2降低了这些影响. HNRNPC过度表达增强了葡萄糖分解和迁移,被CELF2过度表达抵消.
结论:
- HNRNPC/CELF2轴在推动AML进展和化疗耐药性的代谢重编程中起着关键作用.
- 针对HNRNPC/CELF2途径是一个潜在的治疗策略.
- 这种方法可能有助于克服耐药性,并改善AML患者的治疗结果.
更多相关视频
07:58An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
09:44Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Treatment Resistant Cancers
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Hematopoietic Stem Cells
